Serum thyroglobulin (Tg) was measured in 429 patients with well-differentiated thyroid carcinoma, during thyroid hormone suppression therapy. 324 patients out of 429 were considered free of disease; 44 had only remnants in the thyroid bed; 61 had metastases, of them 40 were detected by TBS and 21 were nonfunctioning and were detected by other diagnostic procedures. Tg was measured by a RIA method in 257 patients and by an IRMA method in 277 patients. The correlation between the two methods was very good (r=0.914) for values higher than 25 ng/ml with the RIA method. The cut-off limit to distinguish pathological from nonpathological values was considered the mean value found in the patients free of disease plus 2SD. The cut-off limit for the RIA method was 24.2 ng/ml and 3.0 ng/ml for the IRMA method. Of patients with high Tg levels 92% had metastases, either nodal or distant; only 8% had remnants in the thyroid bed. Tg levels were high in 80% of the patients with metastases, all but two of the patients with metastases and low Tg levels had nodal metastases. Moreover, Tg levels were high in 76% of the patients with metastases unable to take up radioidine. In conclusion: patients with low levels of serum Tg during suppression therapy have a high probability of being free of disease, even though the presence of tumors cannot be excluded. On the other hand a value greater than the cut-off limit suggests the presence of metastases despite a negative scan.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Ashcraft M, Van Herle AJ (1981) The comparative value of serum thyroglobulin measurements and Iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer. Am J Med 71:806–813
Botsch H, Schultz E, Lochner B (1979) Serum-Thyreoglobulinbestimmung zur verlaufskontrolle bei schilddrüsenkarzinom-patienten. Dtsch Med Wochenschr 104:1072–1074
Busnardo B, Vangelista R, Girelli ME, Bui F, Lazzi C (1976) TSH levels and TSH response to TRH as a guide to the replacement treatment of patients with thyroid carcinoma. J Clin Endocrinol Metab 42:901–906
Charles MA, Dodson LE, Waldeck N, Hofeldt F, Ghae N, Telepak R, Ownbey J, Burstein P (1980) Serum thyroglobulin levels predict total body iodine Scan findings in patients with treated well-differentiated thyroid carcinoma. Am J Med 69:401–407
Lo Gerfo P, Stillman T, Colacchio D, Feind C (1977) Serum thyroglobulin and recurrent thyroid cancer. Lancet 23:881–882
Pacini F, Pinchera A, Giani C, Grasso L, Doveri F, Baschieri L (1980) Serum thyroglobulin in thyroid carcinoma and other thyroid disorders. J Endocrinol Invest 3:283–292
Schlumberger M, Fragu P, Parmentier C, Tubiana M (1981) Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinomas: comparison of its value in patients with or without normal residual tissue. Acta Endocrinol 98:215–221
Shah DH, Dandekar SR, Jeevanram RK, Kuma A, Sharma SM, Ganatra RD (1981) Serum thyroglobulin in differentiated thyroid carcinoma: histological and metastatic classification. Acta Endocrinol 98:222–226
Shlossberg AH, Jacobson JC, Ibbertson HK (1979) Serum thyroglobulin in the diagnosis and management of thyroid carcinoma. Clin Endocrinol 10:17–27
Torregiani G, Doniach D, Roitt IM (1969) Serum thyroglobulin levels in healthy subjects and in patients with thyroid disease. J Clin Endocrinol Metab 29:305–314
Van Herle AJ (1977) Serum thyroglobulin levels in patients with differentiated thyroid carcinoma. Ann Radiol 20:743–745
Van Herle AJ, Uller RP (1975) Elevated serum thyroglobulin: a marker of metastases in differentiated thyroid carcinoma. J Clin Invest 56:272–277
Van Herle AJ, Uller RP, Matthews NL, Brown J (1973) Radioimmunoassay for measurement of thyroglobulin in human serum. J Clin Invest 52:1320–1327
About this article
Cite this article
Girelli, M.E., Busnardo, B., Amerio, R. et al. Serum thyroglobulin levels in patients with well-differentiated thyroid cancer during suppression therapy: study on 429 patients. Eur J Nucl Med 10, 252–254 (1985). https://doi.org/10.1007/BF00254469
- Thyroid cancer